Stock Analysis

Have Insiders Sold Andlauer Healthcare Group Shares Recently?

Published
TSX:AND

We wouldn't blame Andlauer Healthcare Group Inc. (TSE:AND) shareholders if they were a little worried about the fact that Ronald Skelton, a company insider, recently netted about CA$887k selling shares at an average price of CA$44.36. That's a big disposal, and it decreased their holding size by 12%, which is notable but not too bad.

Check out our latest analysis for Andlauer Healthcare Group

The Last 12 Months Of Insider Transactions At Andlauer Healthcare Group

In fact, the recent sale by insider Ronald Skelton was not their only sale of Andlauer Healthcare Group shares this year. They previously made an even bigger sale of -CA$4.7m worth of shares at a price of CA$39.83 per share. That means that an insider was selling shares at slightly below the current price (CA$43.42). When an insider sells below the current price, it suggests that they considered that lower price to be fair. That makes us wonder what they think of the (higher) recent valuation. Please do note, however, that sellers may have a variety of reasons for selling, so we don't know for sure what they think of the stock price. This single sale was just 19% of Ronald Skelton's stake.

Over the last year we saw more insider selling of Andlauer Healthcare Group shares, than buying. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

TSX:AND Insider Trading Volume November 13th 2024

I will like Andlauer Healthcare Group better if I see some big insider buys. While we wait, check out this free list of undervalued and small cap stocks with considerable, recent, insider buying.

Does Andlauer Healthcare Group Boast High Insider Ownership?

Many investors like to check how much of a company is owned by insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. It appears that Andlauer Healthcare Group insiders own 1.3% of the company, worth about CA$22m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

So What Do The Andlauer Healthcare Group Insider Transactions Indicate?

Insiders sold Andlauer Healthcare Group shares recently, but they didn't buy any. Zooming out, the longer term picture doesn't give us much comfort. Insider ownership isn't particularly high, so this analysis makes us cautious about the company. We're in no rush to buy! In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Andlauer Healthcare Group. While conducting our analysis, we found that Andlauer Healthcare Group has 1 warning sign and it would be unwise to ignore this.

But note: Andlauer Healthcare Group may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.